Table 1.

Demographic data of adults with AD.

Identification	Gender	Age	EASI	IgE (IU/mL)	Eosinophils %
PC1	M	30	48.4	18300	6.6
PC2	F	22	25	40100	8.2
PC3	F	29	40.6	59500	19.4
PC4	M	21	47.7	39100	11.3
PC5	F	43	33.5	2680	5.7
PC6	M	28	40.2	16700	6.4
PC7	M	24	47.9	3120	10.1
PC8	F	22	10.3	26200	7.8
PC9	M	37	47.4	59900	5.1
PC10	M	43	18.4	28300	12.7
PC11	F	22	31.6	40100	8.2
PC12	F	24	49	21200	5.2
PC13	M	22	17.8	3400	8.7
PC14	M	24	50	46300	22
PC15	M	39	35.4	5080	6.7
PC16	M	20	24.7	26900	36.1
PC17	M	19	25.9	67500	6.4
PC18	M	34	35.8	5530	13.2
PC19	M	24	35	30000	15.2
PC20	M	20	14.4	4910	7.6
PC21	M	21	48.2	54200	9.9
PC22	M	28	47.1	23300	9.1
PC23	M	31	41.9	23800	25
PC24	M	29	11.2	4070	14.2
PC25	M	21	38.5	2870	6.8
PC26	F	42	8.6	5180	9.9
PC27	M	27	51	37600	5.1
PC28	M	19	22	4140	5.9
PC29	F	28	70	45900	14
PC30	M	24	45.8	13100	12
PC31	F	48	8.7	343	1.1
PC32	M	48	41.4	34800	14.9
PC33	F	20	34.8	119000	5.5
PC34	F	25	31.2	13400	9.2
PC35	M	28	35.2	5260	6.6
PC36	M	19	35.2	58400	24.2
PC37	F	31	12	3400	6.9
PC38	M	19	21.4	6050	10.7
HC (n = 40)	18 M/22 F	31.1 (18–53)	NA	<100	<5

PC = patients; M = male; F = female; EASI = eczema area and severity index; AD = atopic dermatitis; HC = healthy controls; NA = not applicable.